ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,729.52
      0.19%
      US Tech 100
      19,438.00
      0.60%
      Dow Jones
      42,141.99
      0.04%
      Brent Oil
      74.415
      0.92%
      Bitcoin
      63,296.07
      -0.05%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Biogen Inc (BIIB)

      7. Biogen Inc (BIIB) Financials

      Biogen Inc

      Biogen Inc (BIIB)

      NASDAQ
      193.995
      -1.82
      ( -0.93% )
      Updated: 12:40:27
      Delayed by 15 minutes

      Biogen Inc Financial Summary

      The current BIIB market cap is 28.26B. The company's latest EPS is USD 7.9712 and P/E is 24.28.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.46B2.53B2.39B2.29B2.46B
      Operating Income 643.8M44.8M775.7M558.5M695.3M
      Net Income 591.6M-68.1M249.7M393.4M583.6M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 14.44B13.62B11.03B10.17B9.84B
      Operating Income 7.04B4.55B3.09B2.76B2.03B
      Net Income 5.89B4B1.81B3.05B1.16B

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 25.16B28.19B26.84B26.57B26.8B
      Total Liabilities 10.7B13.71B12.05B11.35B10.92B
      Total Equity 14.46B14.48B14.8B15.21B15.89B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 27.23B24.62B23.88B24.55B26.84B
      Total Liabilities 13.9B13.93B12.92B11.17B12.05B
      Total Equity 13.34B10.69B10.96B13.39B14.8B

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 942.3M1.53B1.55B553.2M1.18B
      Investing -1.71B-3.45B-4.1B-66M400.5M
      Financing -53.2M795.4M149.3M-439.6M-684.8M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 7.08B4.23B3.64B1.38B1.55B
      Investing 470.5M-608.6M-563.7M1.58B-4.1B
      Financing -5.86B-5.27B-2.09B-1.75B149.3M

      Stats and Ratios

      Market Cap 28.26B
      Price to Earnings Ratio 24.28
      Price to Sales Ratio 2.87
      Price to Cash Ratio 26.85
      Price to Book Ratio 1.9
      Dividend Yield -

      Share Statistics

      Shares Outstanding 145.66M
      Average Volume (1 week) 1.57M
      Average Volume (1 Month) 1.01M
      52 Week Change -24.54%
      52 Week High 269.4312
      52 Week Low 189.44
      Spread (Intraday) 0.07 (0.04%)

      Company Info

      Company Name Biogen Inc
      Address 3411 silverside road tatnall
      wilmington, delaware 19810
      Website https://www.biogen.com
      Industry biological pds,ex diagnstics (2836)

      Your Recent History

      NASDAQ
      BIIB
      Biogen
      Delayed Upgrade Clock